Last reviewed: July 10, 2026
Last updated: July 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has emerged as one of the most effective medications for weight management, with clinical trials showing an average weight loss of 15% over 68 weeks at therapeutic doses. Understanding how dosing works—and how it's personalized for your body—is essential to achieving sustainable results. PlexusDx compounded semaglutide injections start at $189/mo (or $149/mo on the 6-month plan), regardless of your current or future dose level.
How Semaglutide Dosing Works for Weight Loss
Semaglutide is not started at a high dose. Instead, it follows a gradual titration schedule designed to allow your body to adapt and minimize side effects. The standard protocol begins at 0.25 mg injected subcutaneously once weekly, then increases by 0.25 mg every four weeks until reaching a therapeutic dose of 1.0 to 2.4 mg per week. This 16-week ramp-up gives your system time to adjust to the medication's effects on appetite signaling and blood sugar control.
Your ideal therapeutic dose depends on multiple factors: your starting weight, metabolic rate, gastrointestinal tolerance, and genetic predispositions in your peptide pathways. Some patients achieve meaningful weight loss at 1.0 mg weekly, while others require 2.4 mg for optimal results. PlexusDx physicians evaluate your clinical response at each tier, adjusting as needed to find your personal effective dose without increasing your monthly cost.
The Titration Schedule: What to Expect Week by Week
Weeks 1–4: You inject 0.25 mg once per week. During this phase, most patients experience mild nausea or appetite reduction as the medication activates GLP-1 receptors in your brain and gut. Keeping meals smaller and staying hydrated helps manage early side effects. This starting dose is low enough that serious adverse effects are uncommon, though some fatigue or constipation may occur.
Weeks 5–8: Your dose increases to 0.5 mg weekly. By now, appetite suppression becomes more pronounced, and many patients report eating significantly less without conscious restriction. Energy levels often stabilize after the initial adjustment period. Weeks 9–12 bring a 0.75 mg dose, intensifying the weight loss signal while your body continues to adapt.
Weeks 13–16: You reach 1.0 mg weekly, the standard maintenance dose for most weight loss programs. At this point, your physician assesses whether you've reached your target weight loss velocity or if you'd benefit from advancing to 1.7 or 2.4 mg. This decision is individualized—not every patient needs higher doses to see results.
Why Your Dose May Increase—And Why Your Price Won't
As your body adapts to semaglutide over weeks and months, your appetite-suppressing response may gradually diminish—a phenomenon called tachyphylaxis. This doesn't mean the medication stopped working; it means your brain has recalibrated its baseline. To maintain the same level of appetite control and weight loss momentum, your physician may recommend stepping up from 1.0 mg to 1.7 mg, or from 1.7 mg to 2.4 mg. This is a normal, expected part of long-term therapy.
PlexusDx pricing removes this common barrier to dose optimization. Whether you start at 0.25 mg or advance to 2.4 mg, your monthly cost stays flat at $189 for compounded semaglutide injection. You never pay more per dose or encounter surprise fees based on dosage. This transparent model ensures you can prioritize what your body needs without financial penalties for optimization.
Personalized Dosing: The Role of Genetic Testing
Not every patient responds identically to the same dose. Genetic variants in your GLP-1 receptor gene (GLP1R rs6923761), your GIPR pathway (GIPR rs1800437), and your appetite-regulation genes (FTO rs9939609, MC4R rs17782313) influence how sensitively your brain and metabolism respond to semaglutide. A patient with a protective genetic variant in GLP1R may achieve excellent weight loss at 1.0 mg, while someone with different variants might require 2.4 mg to reach the same result.
The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Semaglutide Dosing vs. Tirzepatide: Which Is Right for You?
Semaglutide targets one hormone pathway: GLP-1 signaling. Tirzepatide, by contrast, activates both GLP-1 and GIP receptors (dual agonism). This difference affects dosing strategies. Semaglutide's maximum therapeutic dose is 2.4 mg weekly, while tirzepatide dosing reaches up to 15 mg weekly due to its broader mechanism. For some patients, semaglutide's single-pathway approach delivers sufficient appetite suppression and metabolic benefit. Others achieve better results with tirzepatide's dual effect.
Your choice between semaglutide and tirzepatide depends on your genetic predispositions, tolerance to side effects, and weight loss goals. PlexusDx offers both as compounded injections—semaglutide starting at $189/month and tirzepatide at $289/month—plus hybrid options like GLP-Squared (combining both compounds). Your physician can recommend a starting point based on your peptide genetics and adjust if needed, always at a predictable, flat monthly cost.
Managing Side Effects at Different Dose Levels
Nausea and constipation are the most common side effects during semaglutide titration. At 0.25–0.5 mg, these effects are usually mild and self-limiting. By week 4, many patients report adaptation. If nausea persists or worsens as you titrate, your physician may slow the dose escalation or recommend dietary adjustments (smaller, protein-rich meals) and medication support. Staying hydrated and moving your body regularly also reduce gastrointestinal discomfort.
At higher doses (1.7–2.4 mg), side effects can be more pronounced but remain manageable for most patients. Severe nausea affecting quality of life should always be reported to your physician immediately—it may signal that your optimal dose is lower, or that semaglutide isn't the right fit. PlexusDx physicians monitor your response closely and adjust your regimen to balance weight loss benefits with tolerability. You're never locked into a dose that leaves you feeling unwell.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is a typical starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once per week. This low initial dose allows your body to adapt while minimizing side effects. Over 16 weeks, you gradually increase by 0.25 mg every 4 weeks, reaching a maintenance dose of 1.0 to 2.4 mg weekly depending on your individual response and goals.
How quickly do I see weight loss results with semaglutide?
Most patients notice reduced appetite and early weight loss within the first 2–4 weeks, though the weight on the scale may not change significantly until weeks 4–8. Clinical trials show that after 16–20 weeks at therapeutic doses, average weight loss reaches 5–10% of body weight, with continued progress over 12 months reaching 15% or more.
Will my cost increase if my dose goes up over time?
No. PlexusDx compounded semaglutide injection is priced flat at $189/mo (or $149/mo on the 6-month plan), regardless of whether you're at 0.25 mg or 2.4 mg. Your dose may need to go up. Your price won't. This pricing applies to all commitment tiers and eliminates the financial barrier to dose optimization.
What if I'm not losing weight at my current dose?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
The Precision Peptide Genetic Test analyzes your variants in GLP1R, GIPR, FTO, MC4R, and 45 other peptide genes across 14 metabolic pathways. This reveals your predicted sensitivity to GLP-1 signaling and appetite regulation, helping your physician forecast your likely dose response before you begin titration, so adjustments are more targeted and efficient.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Mounjaro Injection Painful? A Comprehensive Guide to Your Injection Experience
What Happens If You Eat Too Much on Mounjaro: Understanding the Effects